Non-Coding Mutations in Urothelial Bladder Cancer: Biological and Clinical Relevance and Potential Utility as Biomarkers

Ruhana R. Jeeta, Naheema S. Gordon, Laura Baxter, Anshita Goel, Boris Noyvert, Sascha Ott, Rebecca H. Boucher, Nada Humayun-Zakaria, Roland Arnold, Nicholas D. James, Maurice P. Zeegers, K. K. Cheng, Richard T. Bryan, Douglas G. Ward*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)263-272
Number of pages10
JournalBladder Cancer
Volume5
Issue number4
DOIs
Publication statusPublished - 2019

Keywords

  • Bladder cancer
  • non-coding
  • mutations
  • prognosis
  • detection
  • DNA
  • TERT PROMOTER MUTATIONS
  • REGULATORY MUTATIONS
  • RECURRENT

Cite this

Jeeta, R. R., Gordon, N. S., Baxter, L., Goel, A., Noyvert, B., Ott, S., Boucher, R. H., Humayun-Zakaria, N., Arnold, R., James, N. D., Zeegers, M. P., Cheng, K. K., Bryan, R. T., & Ward, D. G. (2019). Non-Coding Mutations in Urothelial Bladder Cancer: Biological and Clinical Relevance and Potential Utility as Biomarkers. Bladder Cancer, 5(4), 263-272. https://doi.org/10.3233/BLC-190251